🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the efficacy and safety of intravenous RC48-ADC co...
Status
Recruiting
Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
Start Date
2022-11-23
Trial ID
NCT05917158
Treatments Being Tested
Objectives: To evaluate the non-inferiority of disitamab vedotin plus gemci...
Status
Recruiting
Location
The First Affiliated Hospital of Anhui Medical University
Start Date
2026-07-01
Trial ID
NCT07693959
Treatments Being Tested
This is a single-arm, open-label, Phase Ib/II clinical trial designed to ev...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-04-30
Trial ID
NCT06957561
The purpose of this study is to evaluate the efficacy and safety of Disitam...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2023-11-28
Trial ID
NCT06178159
Treatments Being Tested
This study is being done to see if a drug called disitamab vedotin, alone o...
Status
Recruiting
Location
Banner Gateway Medical Center
Start Date
2022-05-03
Trial ID
NCT04879329
Treatments Being Tested
In this study, 60 patients with HER2 overexpression UTUC with high-risk rec...
Status
Recruiting
Location
Peking University First Hospital
Start Date
2024-02-20
Trial ID
NCT06210490
Treatments Being Tested
This is a single-center, open-label, dose-escalation phase I clinical study...
Status
Unknown
Location
Remegen
Start Date
2022-09-28
Trial ID
NCT05514158
This is a Phase II/III, randomized, multicenter, open-label clinical trial ...
Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Start Date
2023-08-04
Trial ID
NCT05980481
The purpose of this project is to explore whether Monoclonal Antibody-MMAE ...
Status
Unknown
Location
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Start Date
2021-10-01
Trial ID
NCT05016973
Treatments Being Tested
The goal of this clinical trial is to learn if Disitamab Vedotin combined w...
Status
Recruiting
Location
Fujian Medical University Union Hospital
Start Date
2025-01
Trial ID
NCT06791070
Treatments Being Tested